ScienceDex / Researcher record
Gregor, Paul
- Gismo Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2013 | $197,137 | 1 | #31,400 |
| 2015 | $224,997 | 1 | #29,911 |
| 2016 | $241,938 | 1 | #29,244 |
| 2017 | $1,075,603 | 2 | #6,335 |
| 2018 | $952,480 | 1 | #8,082 |
| 2022 | $983,932 | 1 | #10,056 |
| 2023 | $792,857 | 1 | #13,578 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20131 record
- FY20151 record
- FY20161 record
- FY20172 records
- FY20181 record
- FY20221 record
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Gregor, Paul as a PI. Multi-PI records show the full award amount for context.
- 5R44AG056231-04R44Contact PIAmyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease$792.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Gregor, Paul as a PI.
FY2023 award administered by Gismo Therapeutics, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardGismo Therapeutics, Inc.
- 2016$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #6335
- 2018$2M Cumulative Funding